Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) insider Arnnon Geshuri sold 1,795 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $12,852.20. Following the transaction, the insider now owns 44,914 shares in the company, valued at approximately $321,584.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Teladoc Health Trading Down 2.1 %
TDOC opened at $7.51 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $22.98. The company’s 50 day moving average price is $8.25 and its two-hundred day moving average price is $11.43. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of -5.33 and a beta of 0.90.
Teladoc Health (NYSE:TDOC – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.08. The business had revenue of $642.44 million during the quarter, compared to the consensus estimate of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. As a group, research analysts predict that Teladoc Health, Inc. will post -0.71 earnings per share for the current year.
Hedge Funds Weigh In On Teladoc Health
Analysts Set New Price Targets
TDOC has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $10.00 price objective on shares of Teladoc Health in a report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. Stifel Nicolaus cut their price target on Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research note on Thursday, August 1st. TD Cowen reduced their price objective on shares of Teladoc Health from $15.00 to $9.00 and set a “hold” rating on the stock in a research note on Thursday, August 1st. Finally, DA Davidson decreased their target price on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $12.44.
View Our Latest Stock Report on Teladoc Health
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
- Five stocks we like better than Teladoc Health
- How Technical Indicators Can Help You Find Oversold Stocks
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Stock Analyst Ratings and Canadian Analyst Ratings
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Cloud Security Stocks Face Off: Find Out Who’s Leading the Market
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.